CC
BSX icon

Centiva Capital’s Boston Scientific BSX Stock Holding History

Centiva Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,400
Closed -$197K – 1798
2023
Q4 		$197K Sell
3,400
-10,000
-75% -$534K ﹤0.01% 1444
2023
Q3 		$708K Buy
13,400
+10,000
+294% +$524K 0.02% 796
2023
Q2 		$184K Buy
+3,400
New +$178K ﹤0.01% 1351
2019
Q4 		– Sell
-145,300
Closed -$5.91M – 809
2019
Q3 		$5.91M Buy
+145,300
New +$6.16M 0.36% 50

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Centiva Capital's BSX Position: Q2 2026 in Review

Centiva Capital increased its Boston Scientific (BSX) stake by 315% in Q2 2026, buying an estimated $6.19M and bringing the position to 150,288 shares worth $6.41M. The position accounts for 0.06% of the portfolio, ranked #232.

Centiva Capital first reported a position in BSX in Q3 2019 and has held it in 15 quarters since. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Centiva Capital held 150,288 shares of Boston Scientific worth $6.41M as of Q2 2026.
  • Centiva Capital bought 114,037 Boston Scientific shares in Q2 2026, an estimated $6.19M.
  • Boston Scientific made up 0.06% of Centiva Capital's portfolio in Q2 2026, its #232 holding.
  • Centiva Capital first reported a position in Boston Scientific in Q3 2019 and has held it in 15 quarters since.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.